000			01237na a2200241 4500
003			H12O
005			20180417112759.0
008			130622s2011 xxx||||| |||| 00| 0 eng d
040			_cH12O
041			_aeng
100			_aCortés-Funes Castro, Hernán _91181 _eOncología Médica
100			_aGómez Martín, Carlos _91064 _eOncología Médica
100			_9431 _aGrávalos Castro, Cristina _eOncología Médica
245	0	0	_aPhase II study of trastuzumab and cisplatin as first-line therapy in patients with HER2-positive advanced gastric or gastroesophageal junction cancer _h[artículo]
260			_bClinical and Translational Oncology, _c2011.
300			_a13(3):179-184.
500			_aFormato Vancouver: Grávalos C, Gómez Martín C, Rivera F, Alés I, Queralt B, Márquez A, Jiménez U, Alonso V, et al. Phase II study of trastuzumab and cisplatin as first-line therapy in patients with HER2-positive advanced gastric or gastroesophageal junction cancer. Clin Transl Oncol. 2011;13(3):179-84.
501			_aPMID: 21421462
504			_aContiene 26 referencias
710			_9303 _aServicio de Oncología Médica
856			_uhttp://pc-h12o-es.m-hdoct.a17.csinet.es/pdf/pc/9/pc9518.pdf _ySolicitar documento
942			_n0 _2ddc _cART
999			_c9518 _d9518